Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $44.28 and traded as high as $45.35. Hikma Pharmaceuticals shares last traded at $45.35, with a volume of 149 shares traded.
Hikma Pharmaceuticals Price Performance
The company’s 50 day moving average is $44.28 and its 200-day moving average is $40.91.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets generic and branded medicines. Its products include injectable medicines, oral and other generic treatments, and branded medicines serving a range of therapeutic areas. Founded in Amman, Jordan, in 1978 by Samih Darwazah, the company has grown from a regional pharmaceutical business into an international manufacturer. Hikma operates across the Middle East and North Africa, Europe and the United States, with manufacturing and commercial operations in multiple markets.
Further Reading
- Five stocks we like better than Hikma Pharmaceuticals
- Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
